Medicare Enrolled
Dr. Jeffrey Namey, M.D.
Nuclear Cardiology Physician · Moorestown, NJ
Practice pattern: Electrophysiology & Device
— Practice focused on heart rhythm disorders and cardiac device management
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Namey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Namey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Namey
Dr. Jeffrey Namey is a nuclear cardiology physician in Moorestown, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Namey performed 4,299 Medicare services across 2,953 unique beneficiaries.
Between the years covered by Open Payments, Dr. Namey received a total of $7,473 from 31 pharmaceutical and/or device companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear cardiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Namey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 24% volume in NJ
$7,473 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,299
Medicare services
Top 24% in NJ for nuclear cardiology physician
2,953
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~215 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
991 | $12 | $55 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
925 | $97 | $284 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
777 | $6 | $25 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
372 | $101 | $241 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
231 | $146 | $430 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
184 | $44 | $148 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
176 | $4 | $11 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
156 | $136 | $571 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
73 | $323 | $1,385 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
64 | $51 | $235 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
59 | $146 | $251 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $122 | $365 |
| Physician review of home INR testing A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria. |
44 | $7 | $30 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
42 | $65 | $215 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
28 | $20 | $85 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $67 | $166 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
24 | $17 | $70 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
22 | $11 | $50 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $155 | $395 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
15 | $8 | $27 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
14 | $56 | $300 |
| Heart muscle strain imaging | 11 | $8 | $135 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.6% high complexity
10.5% medium
84.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,473
Total received (2018-2024)
Avg $1,068/year across 7 years
Top 32% in NJ for nuclear cardiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
442
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,719 (89.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$754 (10.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,027
2023
$1,537
2022
$627
2021
$1,124
2020
$450
2019
$1,513
2018
$1,194
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$244
Impulse Dynamics (USA) Inc.
$160
Amgen Inc.
$140
Boston Scientific Corporation
$85
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
Janssen Pharmaceuticals, Inc
$55
PFIZER INC.
$49
Kestra Medical Technology Services, Inc.
$35
Kiniksa Pharmaceuticals International, plc
$33
AstraZeneca Pharmaceuticals LP
$31
Merck Sharp & Dohme LLC
$31
ABIOMED
$24
Regeneron Healthcare Solutions, Inc.
$17
Lexicon Pharmaceuticals, Inc.
$17
AGEPHA Pharma FZ LLC
$16
Actelion Pharmaceuticals US, Inc.
$16
Esperion Therapeutics, Inc.
$16
Top 3 companies account for 53.0% of 2024 payments
All-time payments by company (2018-2024) ›
Impulse Dynamics (USA) Inc.
$1,305
Amgen Inc.
$1,174
Boston Scientific Corporation
$909
Novartis Pharmaceuticals Corporation
$639
Janssen Pharmaceuticals, Inc
$535
E.R. Squibb & Sons, L.L.C.
$425
SANOFI-AVENTIS U.S. LLC
$343
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$335
PFIZER INC.
$298
AstraZeneca Pharmaceuticals LP
$284
Amarin Pharma Inc.
$186
Merck Sharp & Dohme LLC
$179
Regeneron Healthcare Solutions, Inc.
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$99
ATRICURE, INC.
$93
BOSTON SCIENTIFIC CORPORATION
$81
Gilead Sciences, Inc.
$68
Kestra Medical Technology Services, Inc.
$66
Philips Electronics North America Corporation
$66
Edwards Lifesciences Corporation
$48
Esperion Therapeutics, Inc.
$40
Kiniksa Pharmaceuticals International, plc
$33
ABIOMED
$24
Kowa Pharmaceuticals America, Inc.
$24
Abbott Laboratories
$21
Lexicon Pharmaceuticals, Inc.
$17
Kiniksa Pharmaceuticals, Ltd.
$17
AGEPHA Pharma FZ LLC
$16
Actelion Pharmaceuticals US, Inc.
$16
W. L. Gore & Associates, Inc.
$14
Allergan Inc.
$11
Top 3 companies account for 45.3% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (9124) LM Undivided · Alere i · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · CAMZYOS · CARDIOFORM Septal Occluder · CHANTIX · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · FARXIGA · Impella · JARDIANCE · LEQVIO · LODOCO · LOKELMA · LUX DX · LUX-DX · LifeVest · Livalo · MULTAQ · NEXLETOL · OPSUMIT · OPTIMIZER · Optimizer · Optimizer Smart System · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Ranexa · Repatha · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nuclear cardiology physicians within 10 mi
24
Per 100K population
5.2
County median income
$105,271
Nearest hospital
VIRTUA WILLINGBORO HOSPITAL
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Namey is an electrophysiology & device specialist, with above-average Medicare volume (top 24% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Namey experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Namey performed 991 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Namey receive payments from pharmaceutical companies?
Yes. Dr. Namey received a total of $7,473 from 31 companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Namey's costs compare to other nuclear cardiology physicians in Moorestown?
Dr. Namey's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Namey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Nuclear Cardiology Physicians in Moorestown
Browse nuclear cardiology physicians in Moorestown ranked by procedure volume and transparency data.
Highest volume
Top Nuclear Cardiology Physicians in NJ
Nuclear cardiology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nuclear Cardiology Physicians in NJ
Which NJ nuclear cardiology physicians receive the most from drug and device companies.
By company
Impulse Dynamics (USA) Inc. Payments to Doctors
See all physicians who received payments from Impulse Dynamics (USA) Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology